Max India Limited, a prominent player in the Indian healthcare and allied sectors, has successfully raised ₹80.35 crore through a preferential issue of convertible warrants. The company's Board of Directors approved the allotment of 36,19,594 fully convertible warrants at ₹222 per warrant on September 24, 2025.

Warrant Allotment Details

The allotment includes both promoter and non-promoter entities, with the following breakdown:

Key Points of the Preferential Issue

• Total Warrants Issued: 36,19,594
• Issue Price: ₹222 per warrant
• Total Amount Raised: ₹80,35,49,868

Warrant Conversion and Lock-in Period

Each warrant is convertible into one fully paid-up equity share of ₹10 upon payment of the remaining 50% consideration. The allotted securities are subject to lock-in restrictions as per the Securities and Exchange Board of India (SEBI) regulations.

Initial Payment and Future Conversion

Max India has received 50% of the total consideration, amounting to ₹40,17,74,934, at the time of allotment. The balance 50% will be payable upon conversion of the warrants into equity shares.

Regulatory Compliance

The preferential issue was conducted in accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has duly informed the BSE Limited and the National Stock Exchange of India Limited about the allotment.

This strategic move by Max India Limited is expected to strengthen its financial position and support its growth initiatives in the healthcare sector. The participation of both promoter and non-promoter entities in this preferential issue demonstrates confidence in the company's future prospects.

Max India Limited has successfully obtained regulatory approval for relocating its registered office from Maharashtra to the National Capital Territory (NCT) of Delhi. The company received the Regional Director's order on December 16, 2025, marking a significant milestone in its corporate restructuring process.

Regulatory Approval Confirmed

The Regional Director (RD), Western Region, Maharashtra, Ministry of Corporate Affairs issued the approval order dated December 12, 2025, which was received by the company on December 16, 2025. This approval comes in continuation of the company's earlier communication dated August 5, 2025, and follows the special resolution passed by members at the 6th Annual General Meeting held on September 3, 2025.

Compliance Process Completed

The company has successfully navigated the regulatory requirements for the office relocation. The approval has been obtained in accordance with the applicable provisions of the Companies Act, 2013, following the proper filing of applications under Section 13 of the Act.

Next Steps in Implementation

With the Regional Director's approval now secured, Max India Limited will proceed with the final implementation steps:

The company will submit a copy of the altered Memorandum of Association upon receipt of the Certificate of Registration from the Registrar of Companies, New Delhi. The new registered office address will be intimated to stakeholders in due course.

Corporate Governance and Transparency

Throughout this process, Max India Limited has maintained transparency by keeping all stakeholders informed through proper regulatory filings under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company's systematic approach to the relocation demonstrates its commitment to regulatory compliance and corporate governance standards.

This strategic relocation to Delhi positions Max India Limited closer to the regulatory and business hub of the national capital, potentially enhancing its operational efficiency and stakeholder engagement capabilities.